Science Abstracts
Managing neoplastic bone disease with ibandronic acid: a preclinical and clinical data update
September 2010
September 2010
Authors : Martin Pecherstorfer
Affliation : Hematologic-Oncologic Service, Landeklinikum Krems, Mitterweg 10, A-3500 Krems, Austria ; ; martin.pecherstorfer@krems.lknoe.at
DOI : 10.1517/14656566.0.0.348462
Published in : Expert Opin. Pharmacother.
Subject:
Keywords: bisphosphonates , bone metastases , breast cancer , efficacy , ibandronic acid , intravenous , oral , safety
Abstract
Please Login to read the full article.
RELATED CONTENT
COMMENT
Other Informa Comment
FEATURES
- Face-to-Face: Trophos - The French firm that hooked Actelion
- Connexios: Harnessing the Indian cost advantage in network biology
EVENTS
01 January 1970
London, UK
01 January 1970
San Diego, US
01 January 1970
Providence, Rhode Island, and San Francisco, California
JOB OF THE WEEK
Promote your vacancy here
